ID

22010

Beschreibung

Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00316199

Link

https://clinicaltrials.gov/show/NCT00316199

Stichworte

Versionen (1)
  1. 14.05.17 14.05.17 -
Hochgeladen am

14. Mai 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Metastatic Breast Cancer NCT00316199

Englisch

Eligibility Metastatic Breast Cancer NCT00316199

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients of chinese origin with histologically or cytologically proven diagnosis of breast cancer.
Beschreibung

breast cancer, gender, chinese origin

Datentyp

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0152035
unresectable, locally recurrent breast cancer or stage iv disease.
Beschreibung

breast cancer stage, unresectable, locally recurrent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0027646
UMLS CUI [1,3]
C1519810
UMLS CUI [1,4]
C2986682
have at least one measurable lesion as defined by response evaluation criteria in solid tumors (recist) criteria.
Beschreibung

response evaluation criteria in solid tumors

Datentyp

boolean

Alias
UMLS CUI [1]
C1709926
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
Beschreibung

ecog

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
treatment with an anthracycline-based chemotherapy regimen in the adjuvant/neoadjuvant setting with subsequent disease relapse.
Beschreibung

anthracycline-base chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0282564
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy for unresectable, locally advanced breast cancer or metastatic disease.
Beschreibung

breast cancer, unresectable, locally advanced, metastatic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C1519810
UMLS CUI [1,4]
C0677984
UMLS CUI [1,5]
C0027627
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy, and immunotherapy.
Beschreibung

concurrent tumor therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0920425
known or suspected brain metastasis or second primary malignancy that is clinically detectable at the time of consideration for study enrollment.
Beschreibung

brain metastasis, second primary malignancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0751623
active infection or other serious condition.
Beschreibung

infection, comorbidities

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0009488
pregnant or breastfeeding.
Beschreibung

pregnancy, breast feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Metastatic Breast Cancer NCT00316199

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
breast cancer, gender, chinese origin
Item
female patients of chinese origin with histologically or cytologically proven diagnosis of breast cancer.
boolean
C0678222 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0152035 (UMLS CUI [3])
breast cancer stage, unresectable, locally recurrent
Item
unresectable, locally recurrent breast cancer or stage iv disease.
boolean
C0678222 (UMLS CUI [1,1])
C0027646 (UMLS CUI [1,2])
C1519810 (UMLS CUI [1,3])
C2986682 (UMLS CUI [1,4])
response evaluation criteria in solid tumors
Item
have at least one measurable lesion as defined by response evaluation criteria in solid tumors (recist) criteria.
boolean
C1709926 (UMLS CUI [1])
ecog
Item
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
boolean
C1520224 (UMLS CUI [1])
anthracycline-base chemotherapy
Item
treatment with an anthracycline-based chemotherapy regimen in the adjuvant/neoadjuvant setting with subsequent disease relapse.
boolean
C0392920 (UMLS CUI [1,1])
C0282564 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
breast cancer, unresectable, locally advanced, metastatic
Item
prior chemotherapy for unresectable, locally advanced breast cancer or metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1519810 (UMLS CUI [1,3])
C0677984 (UMLS CUI [1,4])
C0027627 (UMLS CUI [1,5])
concurrent tumor therapy
Item
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy, and immunotherapy.
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
brain metastasis, second primary malignancy
Item
known or suspected brain metastasis or second primary malignancy that is clinically detectable at the time of consideration for study enrollment.
boolean
C0220650 (UMLS CUI [1])
C0751623 (UMLS CUI [2])
infection, comorbidities
Item
active infection or other serious condition.
boolean
C0009450 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
pregnancy, breast feeding
Item
pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video